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Abstract The Ile-Lys-Val-Ala-Val (IKVAV) sequence derived
from laminin-1 promotes cell adhesion, neurite outgrowth, and
tumor growth and metastasis. Here, we examined amyloid for-
mation of an IKVAV-containing peptide (LAM-L: AASIK-
VAVSADR, mouse laminin K1 chain 2097^2108). The LAM-
L peptide was stained with Congo red and exhibited ¢brils in
electron microscopy with a characteristic cross-L X-ray di¡rac-
tion pattern. Further, infrared spectra of LAM-L suggested a
L-sheet structure. These results indicate that LAM-L forms
amyloid-like ¢brils. We also examined amyloid-like ¢bril for-
mation of LAM-L analogs. The neurite outgrowth activity of
the LAM-L analogs was closely related to their amyloid-like
¢bril formation.
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1. Introduction
Laminins, the major components of basement membranes,
comprise a family of large heterotrimeric glycoproteins [1]. So
far, ¢ve K, three L, and three Q chains have been identi¢ed,
and at least 15 isoforms are formed by various combinations
of each subunit [2^4]. Laminin-1, consisting of three chains
designated K1, L1, and Q1, has diverse biological activities
including promotion of cell adhesion, migration, neurite out-
growth, tumor metastasis, and angiogenesis [1]. Laminin-1 is
over-expressed in both Alzheimer’s and Down’s brains [5],
especially in the frontal cortex of Alzheimer’s disease [6].
These ¢ndings suggest that laminin K1 chain has a potential
to be involved in the Alzheimer’s disease.
Several active sequences of laminin-1 have been identi¢ed
using synthetic peptide approaches [7^11]. An Ile-Lys-Val-
Ala-Val (IKVAV) sequence located on the C-terminal end
of the long arm of the K1 chain promotes cell adhesion, neu-
rite outgrowth, angiogenesis, collagenase IV production, and
tumor growth [12^16]. A 110 kDa membrane-associated lam-
inin-binding protein from brain binds to the IKVAV site and
functions to promote neurite outgrowth on IKVAV [17]. This
membrane protein has been identi¢ed as L-amyloid precursor
protein [18].
Recently, several peptide segments of proteins were shown
to self-assemble and to form amyloid-like ¢brils [19,20]. Amy-
loid-like ¢brils bind to Congo red [21] and appear as uniform
unbranched ¢brils [22]. Congo red binding analysis is a quick
method for determination of amyloid-like ¢bril formation
[21^24] and is widely used for determination of amyloid-like
structures. The mechanism of the Congo red interaction is not
well understood [25,26]. Amyloid-like ¢brils play a critical
role in various diseases, including Alzheimer’s, the transmis-
sible spongiform encephalopathies, type II diabetes mellitus,
and systemic polyneuropathies [27^29]. Laminin and its frag-
ments interact with L-amyloid proteins, inhibit ¢bril forma-
tion, and are present in Alzheimer’s plaques [30].
Using Congo red staining, electron microscopy, X-ray dif-
fraction, and infrared (IR) spectroscopy, we describe amyloid-
like ¢bril formation of the IKVAV-containing 12-mer peptide
LAM-L, derived from the laminin K1 chain. Structural re-
quirements of the IKVAV-containing peptides for amyloid-
like ¢bril formation are also evaluated.
2. Materials and methods
2.1. Synthesis of peptides
All peptides were synthesized manually by 9-£uorenylmethyloxycar-
bonyl (Fmoc)-based solid-phase methods and puri¢ed by reverse-
phase high performance liquid chromatography (HPLC) as described
previously [16,31]. Purity of the peptides was con¢rmed by analytical
HPLC. Identity of the peptides was con¢rmed by analysis in a mass
spectrometer.
2.2. Congo red binding analysis
Peptide solution in phosphate-bu¡ered saline (PBS) (0.1^2.5 mg/ml)
and Congo red solution (100 WM in PBS) were mixed and incubated
in disposable cuvettes for various times at room temperature. Absorp-
tion spectra were measured from 300 to 700 nm using a U-2000A UV-
Vis Spectrophotometer (Hitachi Co. Ltd., Tokyo, Japan).
2.3. Congo red staining and polarized light microscopy
LAM-L was dissolved in PBS at a concentration of 5 mg/ml, and
the solution was pipetted onto a glass slide. After drying overnight,
the precipitate was stained with a 1% aqueous solution of Congo red
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for 1 h. After rinsing with pure acetone, the samples were dehydrated
with 95% ethanol and 100% ethanol and then cleared with xylene. The
specimens were mounted with a resin (malinol, Muto pure chemicals,
Tokyo, Japan) and observed in a microscope (AX80, Olympus, To-
kyo, Japan) either under bright ¢eld illumination or between crossed
polars.
2.4. Electron microscopy
A grid mesh was coated with a thin Formvar (polyvinyl formal, Oh-
ken, Tokyo, Japan) ¢lm and then stabilized by evaporating a carbon
layer. LAM-L gel in PBS (5 mg/ml) was applied on the grid mesh and
then stained with a 5% aqueous solution of uranyl acetate and ob-
served using a JEM-1200EX (JEOL, Tokyo, Japan) electron micro-
scope at an acceleration voltage of 80 kV.
2.5. X-ray di¡raction
LAM-L, dissolved in H2O (5 mg/ml), was packed into a siliconized
capillary glass tube (P 10 Wm, Verpackung ges, Berlin, Germany), and
dried for 3 days in a wetting box at room temperature. The precipitate
of LAM-L was produced at the top of the capillary glass tube.
X-ray di¡raction patterns were obtained at room temperature using
CuKK (V=1.5418 AS ) radiation from a M18XXHF (50 kV, 90 mA,
MAC Science Co., Ltd., Yokohama, Japan) with double focusing
mirrors. Data were collected on a DIP-R300 di¡ractometer (MAC
Science). The specimen-to-¢lm distance was set at 150 mm and the
exposure time was 30 min. X-ray di¡raction patterns were displayed
and measured using the xdisp (MAC Science).
2.6. Fourier transform IR spectrometer
Aqueous LAM-L solution (50 Wl, 5 mg/ml LAM-L in H2O) was
applied onto a Te£on0 plate, dried for 2 weeks in a wetting box at
room temperature, and then stripped from the plate. The IR absorp-
tion spectra for the dried LAM-L were measured by KBr methods
using a Fourier transform IR spectrometer (RT-210, Horiba Co.,
Ltd., Kyoto, Japan). The IR spectrum was measured with a resolution
of 4 cm31.
3. Results
3.1. Congo red staining analysis
The ability of a laminin K1 chain active peptide LAM-L
(AASIKVAVSADR) and the scrambled peptide LAM-RM to
form amyloid-like ¢brils was tested using Congo red [32,33].
The absorption spectrum of the Congo red solution showed a
peak at 486 nm as described previously [34] (Fig. 1A). When
the Congo red solution was incubated with LAM-L for 24 h,
two larger peaks at 512 and 536 nm appeared (Fig. 1A). The
absorbance at 512 and 536 nm speci¢cally increases when
Congo red binds to amyloid-like ¢brils, such as amyloid
L-peptides [34^36]. LAM-RM had a small e¡ect on the ab-
sorption spectrum of Congo red, but the absorbance at 512
and 536 nm was not signi¢cantly increased. These results sug-
gest that the LAM-L peptide binds to Congo red in a se-
quence-speci¢c manner.
Next, LAM-L solution (5 mg/ml) was pipetted onto a slide
glass, dried, and stained with Congo red. When the sample
was observed under a polarizing microscope, the peptide pre-
cipitate exhibited birefringence, going from red to green (Fig.
1B and C). These results further suggest that the LAM-L
peptide forms amyloid-like structure and signi¢cantly binds
to Congo red.
3.2. Formation of amyloid-like ¢brils
We next examined amyloid-like ¢brils formed by self-as-
sembly of LAM-L. The LAM-L peptide was dissolved in
PBS and analyzed by negative staining electron microscopy.
The LAM-L solution (5 mg/ml in PBS) formed a gel which
had the appearance of amyloid-like ¢brils (Fig. 2). This result
strongly suggests that the LAM-L peptide self-assembles and
forms amyloid-like ¢brils.
Fig. 1. Absorption spectra of Congo red solution in the presence of
peptides and photomicrographs of the LAM-L peptide stained with
Congo red. A: Congo red solution (100 Wl, 100 WM in PBS) and
peptide solution (500 Wl, 2 mg/ml in PBS) were mixed in PBS (400
Wl) at room temperature for 24 h and UV spectra were measured
from 300 to 700 nm. B and C: LAM-L in PBS (5 mg/ml) was pi-
petted onto a glass slide. After drying overnight, the precipitate was
stained with 1% aqueous solution of Congo red for 1 h. After rins-
ing with pure acetone, the samples were dehydrated with 95% etha-
nol and 100% ethanol and then cleared with xylene. The specimens
were mounted with a resin and observed in a microscope either
under bright ¢eld illumination (A) or between crossed polars (B).
Fig. 2. Electron micrograph of amyloid-like ¢brils. LAM-L (1 mg)
was dissolved in PBS (200 Wl), and the resulting gel was kept at 4‡C
for 1 week. The amyloid-like ¢brils were stained with a 5% aqueous
solution of uranyl acetate and observed using an electron micro-
scope.
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The X-ray di¡raction pattern of the LAM-L gel showed
two major re£ections that appear as rings due to the poor
alignment of the ¢brils (Fig. 3). A dominant sharp re£ection
was observed at a position corresponding to 4.6 AS and a
weaker one was observed at 9.3 AS (Fig. 3). These re£ections
are characteristic of the cross-L conformation described for
many amyloid ¢brils [19,22]. In well-oriented amyloid ¢bril
samples, the 4.6 AS re£ection is a characteristic distance and
corresponds to the interstrand spacing in the cross-L confor-
mation, while the 9.3 AS one is equatorial and corresponds to
the intersheet spacing [19,22]. The X-ray data suggest that the
LAM-L peptide forms a cross-L conformation.
The IR spectrum of the LAM-L, determined using the KBr
method, showed one prominent band at 1635 cm31 in the
amide I region (Fig. 4). An amide group in the L-sheet con-
formation gives rise to highly diagnostic bands between ap-
proximately 1620 and 1640 cm31 in the amide I region [37,38].
The IR spectra of the LAM-L suggest that the peptide pos-
sesses a L-sheet conformation in the dried state. In addition, a
L-sheet conformation of LAM-L in dried state was also con-
¢rmed by the circular dichroism (CD) spectrum (data not
shown). A similar CD spectrum was previously obtained
with LAM-L in methanol [16].
3.3. Congo red staining analysis of LAM-L analogs
Amyloid-like ¢brils formed from LAM-L analogs (Table 1)
were analyzed by Congo red analysis (Fig. 5). The analog
peptides were designed based on 12-mers containing the IK-
VAV sequence and having cell adhesion and neurite out-
growth activity [31]. Congo red solution was mixed with pep-
tides and then the absorbance at 536 nm was measured at
various times (Fig. 5). An all-D-con¢guration peptide,
LAM-D, a mirror image compound of LAM-L, shifted the
absorption spectrum of the Congo red solution similar to that
observed with LAM-L (Fig. 5), while LAM-LR and LAM-
Table 1
E¡ect of IKVAV analog peptides on PC12 cells attachment and neurite outgrowth and Congo red binding
Peptide Sequencea Cell attachmentb Neurite outgrowthb Congo red assayc
LAM-L AASIKVAVSADR ++ ++ ++
LAM-D AASIKVAVSADR ++ + ++
LAM-LR RDASVAVKISAA 3 N.D. 3
LAM-DR RDASVAVKISAA 3 N.D. 3
LAM-RM AASVVIAKSADR 3 N.D. 3
LAM-KR AASIRVAVSADR ++ + +
LAM-KE AASIEVAVSADR 3 N.D. 3
LAM-IL AASLKVAVSADR + 3 3
LAM-IX AASXKVAVSADR ++ + ++
LAM-IV AASVKVAVSADR ++ 3 3
LAM-IA AASAKVAVSADR 3 N.D. 3
AG73 RKRLQVQLSIRT ++ ++ 3
AG73T LQQRRSVLRTKI 3 3 3
aD-con¢guration amino acids are indicated by the underline. Substituted amino acids are indicated in bold.
bCell attachment and neurite outgrowth activities of the peptides were described previously [16,31,43].
cThe Congo red assay was evaluated on the following subjective scale: ++, activity comparable to that of LAM-L; +, activity weaker than
that of LAM-L; 3, inactive. N.D. denotes not done.
Fig. 4. Fourier transform IR spectrum (KBr method) of LAM-L.
Aqueous LAM-L solution was applied onto a Te£on0 plate, dried
for 2 weeks in a wetting box, and then stripped from the plate.
Fig. 3. X-ray di¡raction pattern of LAM-L. Two major re£ections
of the amyloid ¢brils (4.6 and 9.3 AS ) are marked by arrows. Due to
the poor alignment of ¢brils, those re£ections appear as rings.
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DR, all-L and all-D reverse-sequence peptides that are bio-
logically inactive, did not a¡ect the absorption spectrum of
the Congo red solution. These results suggest that the e¡ect
on the absorption spectrum of Congo red correlates with the
biological function.
LAM-L analog peptides with single amino acid substitu-
tions were also tested for their e¡ect on the absorption spec-
trum of the Congo red solution (Fig. 5). Analogs in which the
lysine residue in LAM-L was replaced with either arginine or
glutamic acid (LAM-KR and LAM-KE, respectively) were
used (Table 1). Analogs in which the isoleucine residue in
LAM-L was substituted with either leucine, norleucine, valine,
or alanine (LAM-IL, -IX, -IV, and -IA, respectively) were also
tested (Table 1). LAM-KR and LAM-IX increased UV ab-
sorbance at 536 nm, but all other analogs were inactive (Fig.
5). These results suggest that the isoleucine and lysine posi-
tions in the IKVAV sequence are important for amyloid-like
formation as well as for the biological activity.
4. Discussion
Here, we have demonstrated that biologically active laminin
peptides containing the IKVAV sequence can form amyloid-
like ¢brils. Amyloid structure, self-assembly of L-sheet do-
mains resulting in the formation of an ordered ¢brillar struc-
ture, is a common feature of various medical disorders. These
include infectious prion diseases, e.g. bovine spongiform en-
cephalopathy or Creuzfeldt^Jacob disease, amyloidoses, such
as Alzheimer’s disease or type II diabetes, and Huntington’s
disease [27^29,39]. Characteristic for these diseases is that am-
yloidogenic precursor proteins are converted into insoluble
pathogenic protein ¢brils (amyloids). We focused on the IK-
VAV sequence-containing peptide LAM-L and examined its
amyloid-like ¢bril formation. When the peptides were exam-
ined using Congo red, LAM-L strongly shifted the absorption
spectrum of Congo red. Similar shifts to the long wavelength
have been observed for amyloid-like structures, such as with
amyloid L-peptides [33^36]. When the LAM-L gel was stained
with Congo red, the peptide precipitate exhibited birefrin-
gence, going from red to green. Additionally, micro¢brils
were observed when LAM-L was examined by electron mi-
croscopy. Further, X-ray di¡raction and IR analysis indicated
that the ¢brils possessed a L-sheet structure. These results
suggest that the LAM-L peptide promotes the formation of
an amyloid-like structure. Moreover, a structure activity study
using Congo red staining and the cell adhesion and neurite
outgrowth activity with the LAM-L peptide and its analog
peptides suggested that the amyloid-like formation of the IK-
VAV peptides correlated with biological activity. These results
suggest that the IKVAV-containing laminin K1 chain peptides
form amyloid-like ¢brils and play a critical role in biological
activity.
The all-D peptide (LAM-D), previously shown to have cell
attachment and neurite outgrowth activities [16,31], promoted
amyloid-like ¢bril formation as well as that of LAM-L (Table
1), while the reverse-sequence all-L and all-D peptides (LAM-
LR and LAM-DR, respectively) were not biologically active
and did not promote amyloid-like ¢bril formation. These re-
sults indicate that both all-L and all-D IKVAV peptides can
self-assemble and form amyloid-like ¢brils, however, the all-L
and all-D VAVKI-containing peptides (a reverse sequence of
IKVAV peptide) cannot self-assemble. Additional structure
activity studies using LAM-L analogs with single amino
acid substitutions suggested that amyloid-like ¢bril formation
and biological activity were correlated (Table 1). Thus, the
structural requirements of the IKVAV peptide for interaction
with its cell surface receptor or binding proteins are speci¢ed
by the primary structure.
Laminin interacts with various amyloid proteins and may
be involved in amyloid formation [18,30,40,41]. The IKVAV-
containing peptides interact with the 110 kDa amyloid pre-
cursor protein [18]. Laminin binds to L-amyloid protein and
inhibits ¢bril formation, suggesting that the binding peptide
segment may have potential for therapeutic use in inhibition
of L-amyloid protein ¢brillogenesis [30]. The binding site of
L-amyloid protein is likely localized in the C-terminal region
of the laminin K1 chain [30]. The IKVAV sequence may be
involved in the laminin^L-amyloid protein interaction.
Recently, we identi¢ed 72 active peptides from 673 over-
lapping peptides covering the laminin-1 molecule using the
peptide-coated plate and peptide-conjugated Sepharose bead
assays [8^11]. 28 peptides promoted cell attachment in both
assays. 49 peptides showed cell attachment activity only in the
peptide-coated plate assay, and 51 peptides were active only in
the peptide-conjugated Sepharose bead assay. Some of the
peptides that showed activity in both assays were found to
interact with integrins and syndecans [8^11,42]. In this study,
we used the most active peptide of the laminin K1 chain AG73
(LQVQLSIR) as a control. AG73 promoted cell attachment in
both peptide-coated plate and peptide-conjugated Sepharose
bead assays, while it did not a¡ect the absorption spectrum of
the Congo red solution (Table 1 and Fig. 5). LAM-L was
active only in the plate assay. It is possible that the peptides
Fig. 5. Congo red staining of LAM-L analogs (time course). Congo
red solution (100 Wl, 100 WM in PBS) and peptide solution (100 Wl,
1 mg/ml in PBS) were mixed in PBS (800 Wl) and absorption at 536
nm was measured at various times.
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that were only active in the peptide-coated plate coat assay
may form an amyloid-like formation similar to that of the
IKVAV peptide, but this has not yet been tested.
Laminin may have a potential role in Alzheimer’s disease
[5,6]. Laminin and its fragments also have been suggested to
be involved in the amyloid formation [5,6,30]. In this study,
we described the IKVAV peptide formed amyloid-like ¢brils.
These ¢ndings suggest that the amyloid-like ¢bril formation of
the IKVAV region may play a critical role in biological func-
tion.
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